Some people, such as those with terminal illnesses, are willing (even anxious) to try untested therapies. Researchers may not know what results to expect, and they may even anticipate negative outcomes. Who should decide whether the patient undergoes untested therapies? Should public money be used in these cases?
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here